RxDoctor Payments Data

Isaac Sparks, DO

Family Medicine · Greensboro, NCNPI 1205276086

Payments from drug & device makers

$532in general payments, 2019–2025

Across 32 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$159
  • Amgen$53
  • Boehringer Ingelheim$48
  • Astellas Pharma US Inc$46
  • Bayer$37
  • Lilly USA, LLC$32
  • plus $158 from 8 others

What the payments were for

  • Food & beverage$532100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$532 in reported general payments places this provider in the 60th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$31,435
Medicare patients
162
Services billed
825

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban37$24,393
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$23,567
TrulicityDulaglutide11$19,449
Soliqua 100-33Insulin Glargine/Lixisenatide17$15,361
OzempicSemaglutide14$13,667
SymbicortBudesonide/Formoterol Fumarate17$6,433
Combivent RespimatIpratropium/Albuterol Sulfate12$6,102
Atorvastatin Calcium193$2,218
Omeprazole76$1,681
Albuterol Sulfate HfaAlbuterol Sulfate41$1,211
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,196
Celecoxib30$943
Metformin Hcl ErMetformin Hcl87$909
Rosuvastatin Calcium54$839
Levothyroxine Sodium49$608

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$25$23,56729 claims
Lilly USA, LLCTrulicity$32$19,44911 claims
Novo NordiskOzempic$159$13,66714 claims
AstraZenecaSymbicort$31$6,43317 claims
Boehringer IngelheimCombivent Respimat$48$6,10212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →